These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3172136)

  • 21. Synthesis of possible metabolites of 1-cyclopropyl-1,4-dihydro-6-fluoro-5-methyl-7-(3-methyl-1-piperazinyl)- 4-oxo-3-quinolinecarboxylic acid (Grepafloxacin, OPC-17116).
    Morita S; Otsubo K; Matsubara J; Ohtani T; Kawano Y; Ohmori K; Ohguro K; Uchida M
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2246-52. PubMed ID: 8582026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute oral toxicity of the new quinolone antibacterial agent levofloxacin in mice, rats and monkeys.
    Kato M; Furuhama K; Yoshida M; Akahane K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):365-6. PubMed ID: 1622433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of nephrotoxic effects of the new quinolone antibacterial agent levofloxacin in rabbits.
    Inage F; Kato M; Yoshida M; Akahane K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):395-7. PubMed ID: 1622439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 7-Azetidinylquinolones as antibacterial agents. 3. Synthesis, properties and structure-activity relationships of the stereoisomers containing a 7-(3-amino-2-methyl-1-azetidinyl) moiety.
    Frigola J; Vañó D; Torrens A; Gómez-Gomar A; Ortega E; García-Granda S
    J Med Chem; 1995 Mar; 38(7):1203-15. PubMed ID: 7707323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and structure-activity relationships of new 7-[3-(fluoromethyl)piperazinyl]- and -(fluorohomopiperazinyl)quinolone antibacterials.
    Ziegler CB; Bitha P; Kuck NA; Fenton TJ; Petersen PJ; Lin YI
    J Med Chem; 1990 Jan; 33(1):142-6. PubMed ID: 2104934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin.
    Tanaka M; Otsuki M; Une T; Nishino T
    J Antimicrob Chemother; 1990 Nov; 26(5):659-66. PubMed ID: 2079448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antipseudomonal activities of some ofloxacin esters as prodrugs.
    Ertan M; Palaska E; Ertan R; Yuluğ N
    Arzneimittelforschung; 1992 Jan; 42(1):70-2. PubMed ID: 1586384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimycoplasmal activity of ofloxacin (DL-8280).
    Osada Y; Ogawa H
    Antimicrob Agents Chemother; 1983 Mar; 23(3):509-11. PubMed ID: 6573869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro and in-vivo antibacterial activity of CFC-222, a new fluoroquinolone.
    Kim JH; Choi KH; Kim JW; Lee JH; Choi EC; Kim BK
    J Antimicrob Chemother; 1998 Feb; 41(2):223-9. PubMed ID: 9533464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1-Substituted 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8- difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative structure-activity relationships at N1 for the quinolone antibacterials.
    Domagala JM; Heifetz CL; Hutt MP; Mich TF; Nichols JB; Solomon M; Worth DF
    J Med Chem; 1988 May; 31(5):991-1001. PubMed ID: 2834557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibacterial activities and pharmacokinetics of E-4767 and E-5065, two new 8-chlorofluoroquinolones with a 7-azetidin ring substituent.
    Gargallo-Viola D; Ferrer S; Tudela E; Robert M; Coll R; Roser R; Guinea J
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3113-21. PubMed ID: 11600365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, antibacterial activity, and toxicity of 7-(isoindolin-5-yl)-4-oxoquinoline-3-carboxylic acids. Discovery of the novel des-F(6)-quinolone antibacterial agent garenoxacin (T-3811 or BMS-284756).
    Hayashi K; Takahata M; Kawamura Y; Todo Y
    Arzneimittelforschung; 2002; 52(12):903-13. PubMed ID: 12572531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibacterial activity of ofloxacin and other 4-quinolone derivatives: in-vitro and in-vivo comparison.
    Chantot JF; Bryskier A
    J Antimicrob Chemother; 1985 Oct; 16(4):475-84. PubMed ID: 3864775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on pyridonecarboxylic acids. III. Synthesis and antibacterial activity evaluation of 1,8-disubstituted 6-fluoro-4-oxo-7-piperazinyl-4H-[1,3]thiazeto[3,2- a]quinoline-3-carboxylic acid derivatives.
    Segawa J; Kazuno K; Matsuoka M; Shirahase I; Ozaki M; Matsuda M; Tomii Y; Kitano M; Kise M
    Chem Pharm Bull (Tokyo); 1995 Jan; 43(1):63-70. PubMed ID: 7895308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Canadian ofloxacin susceptibility study: a comparative study from 18 medical centers. Canadian Ofloxacin Study Group.
    Hoban DJ; Jones RN
    Chemotherapy; 1995; 41(1):34-8. PubMed ID: 7875019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Synthesis and antibacterial activity of 7-(7-aminomethyl-5-azaspiro [2,4] hept-5-yl)-1-cyclopropyl-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid and its analogues].
    Qi JJ; Guo HY; Liu ML; Sun LY
    Yao Xue Xue Bao; 2004 Mar; 39(3):184-9. PubMed ID: 15171652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Amino-7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6,8-difluoro-1,4- dihydro-4-oxo-3-quinolinecarboxylic acid (PD 124,816). Synthesis and biological evaluation of a new class of quinolone antibacterials.
    Domagala JM; Hagen SE; Hutt MP; Sanchez JP; Sesnie J; Trehan AK
    Drugs Exp Clin Res; 1988; 14(7):453-60. PubMed ID: 2853667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation rates to 4-quinolone resistance.
    Smith JT
    Arzneimittelforschung; 1990 Jan; 40(1):65-8. PubMed ID: 2111135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.